Employees at OpenAI and Anthropic have collectively cashed out about $14 billion by selling vested shares — and neither company has gone public, per The Information. That figure is worth pausing on, because the headline most people take from it is the wrong one.
The story isn't that a handful of AI employees got rich. It's that turning private-company equity into cash before an exit has quietly become normal, repeatable, and very large. For anyone holding shares in a private company, the practical question is no longer "will I ever get liquidity?" It's "how do I think about the liquidity that already exists?"
This article breaks down what the $14 billion actually represents, why it's a market-wide signal rather than an AI curiosity, how this kind of pre-IPO liquidity works in plain English, why abundant liquidity doesn't automatically mean you should sell, and what the scale of it all means for shareholders weighing their own decision.
Key concept
The $14 billion cashed out by OpenAI and Anthropic employees is the visible edge of a broader shift: US startup tender offers reached roughly $18.4 billion in 2025 across a record number of deals, per PitchBook, even as IPO activity stayed depressed. Secondary transactions — not IPOs — have become the primary mechanism through which employees convert private equity into cash. That changes the shareholder's decision from whether liquidity is possible to whether and when to use it.
What the $14 billion actually represents
The $14 billion is a cumulative, cross-company figure: it reflects employee share sales at OpenAI and Anthropic over recent rounds of liquidity, not a single transaction. The largest single piece is OpenAI's secondary sale that closed in October 2025, in which more than 600 current and former employees sold roughly $6.6 billion of stock at a $500 billion valuation, with some sellers permitted to cash out up to $30 million each, per CNBC.
The important detail is the mechanism. None of this came from an IPO. It came from tender offers and secondary purchases — existing investors or the company itself buying shares directly from employees while the company stays private. The release valve that used to require a public listing now operates entirely within the private market.
Example
In OpenAI's October 2025 secondary, an employee selling the maximum permitted $30 million did so at a $500 billion company valuation — a price discovered through a structured buyer process, not a stock exchange. The shares stayed private. The cash was real. That combination — public-market-sized liquidity inside a private company — is the thing that is genuinely new at this scale.
Why this is a market-wide signal, not an AI story
It's tempting to file $14 billion under "AI exceptionalism" and move on. The numbers underneath argue otherwise. Across US startups, tender offers reached about $18.4 billion in 2025 over a record number of deals, and the pace continued into 2026, per PitchBook. The AI names are simply the largest, most visible instances of a mechanism that now runs across the late-stage market.
Two structural facts explain why. First, companies stay private far longer than they used to — the average path from founding to IPO now exceeds a decade. Second, the public exit has narrowed: US IPO activity in 2026 has run roughly 55% below the prior year. When the on-ramp to public markets shrinks and the time horizon stretches, the pressure to provide liquidity some other way builds. Tenders and secondaries are how that pressure gets released.
This is also why the activity clusters where it does. The liquidity is heavily concentrated in a small set of elite companies — the same dynamic we examined in why the venture secondary market is roughly 86% concentrated in 20 companies, and in the broader 2026 private-market bifurcation between the top tier and everyone else. The $14 billion figure is what concentration looks like when you measure it in employee cash-outs.
Pre-IPO liquidity, in plain English
If the headlines have outrun the mechanics, here's the plain version. A secondary transaction is a sale of existing shares in a private company — your shares — as opposed to a primary transaction, where the company issues new shares to raise money. The buyer is a new or existing investor; the seller is an employee, founder, or early backer.
A tender offer is one organized form of secondary. The mechanics typically run in a fixed sequence:
Step 1: Announcement. The company, an existing investor, or a new buyer announces an offer to purchase shares at a set price, with eligibility rules (often by tenure or share class) and a participation window.
Step 2: Election. Eligible shareholders decide whether to sell, and how much, up to any per-person cap. In OpenAI's case, that cap was $30 million per seller.
Step 3: Clearing and transfer. The company's transfer restrictions and right of first refusal (ROFR) are applied, the sale clears at the offered price, and proceeds are paid out.
Outside an organized tender, a shareholder can also sell individually to a qualified buyer — but the same transfer restrictions and ROFR still apply. Either way, price discovery in the private market doesn't happen on an exchange; it happens through a buyer process. For a fuller walkthrough of how that price gets set relative to the last funding round, see how private shares are priced and the secondary discount.
The "champagne problem": abundant liquidity doesn't mean you should sell
Here's the part the $14 billion headline obscures. The same period that produced record cash-outs also produced record holdouts. When Anthropic completed an employee tender at a $350 billion pre-money valuation in early 2026, many employees chose to hold their shares rather than sell, betting on a higher valuation in a future IPO, per Bloomberg.
That's the real signal. When liquidity is scarce, "should I sell?" answers itself — you take the rare chance to get cash. When liquidity is abundant and recurring, the question genuinely opens up. Selling stops being a one-time event you grab and becomes a decision you can make deliberately, in pieces, on your own timeline.
⚠️ Abundant liquidity is not the same as a recommendation to use it. The availability of a buyer says nothing about whether selling fits your situation, your share class, or your timeline. Those are separate questions — and they're the ones that actually matter.
What this signals for shareholders
If you hold shares in a private company — AI or otherwise — the scale of recent cash-outs carries a few concrete implications.
1. The IPO is no longer the only liquidity event. For years, the working assumption was: hold until the company goes public, because there's no other way out. The $14 billion proves that assumption obsolete for an expanding set of companies. Liquidity can exist years before — or instead of — a public listing. The same pattern is reshaping the exit landscape more broadly, which we cover in why the exit market is reopening even as the IPO keeps shrinking.
2. Selling is no longer all-or-nothing. Because these mechanisms recur, a partial sale — taking some risk off the table while keeping upside — is a real option, not a hypothetical. Concentration is the underlying issue: when a large share of your net worth sits in one illiquid private stock, the question isn't whether the company is good, it's whether the concentration is prudent for you.
3. What you hold still determines what you get. Headline valuations apply to the company, not necessarily to your shares. Common stock behind a large preferred stack can be worth far less per share than the last round implies — the mechanics we unpack in the last-round valuation myth. Before any sale, knowing your share class and its realistic value matters more than the headline number.
4. Timing carries tax and personal consequences. When and how you sell affects holding-period treatment and your overall tax picture, and depends on circumstances no article can know. This is not tax advice. Consult a qualified tax professional before you sell private company shares. For a general overview of the considerations, see our guide to tax considerations in a secondary sale.
For more on this topic
For a structured walk through the considerations behind the sell-or-hold decision, see our Shareholder IQ guide to whether to sell your startup shares.
The takeaway
The $14 billion is not a story about AI windfalls. It's evidence that the private market has built its own liquidity layer — large enough, repeatable enough, and concentrated enough that the old "wait for the IPO" default no longer describes how shareholders at leading private companies actually get paid.
For shareholders, that's genuinely good news and a genuinely harder decision at the same time. The constraint used to be access. Increasingly, the constraint is judgment: knowing what you hold, what it's worth, how concentrated you are, and what a deliberate, partial, or patient approach looks like for your situation. The buyers are there. The better question is what you want to do about it.
Have questions about pre-IPO liquidity?
We're happy to share our perspective.
If you're holding private shares and trying to think through whether, when, and how much to sell, we'd encourage you to reach out. We're always glad to talk through how this market works — no commitment required.
Get in touch →contact@earlyasset.com · We typically respond within one business day
Earlyasset, Inc. does not provide investment advice and is not a registered investment adviser. Pricing estimates are algorithmic and do not constitute an offer to buy or sell securities. All transactions respect the company's right of first refusal (ROFR) and any transfer restrictions in your equity agreements. Direct liquidity is provided by Earlyasset Capital, LLC, a separate entity from Earlyasset, Inc.
Source note: Information about OpenAI's and Anthropic's employee share sales is based on public reporting by The Information, CNBC, Bloomberg, and PitchBook as of June 2026. Earlyasset is not affiliated with OpenAI, Anthropic, or any company named here and has no non-public information about these transactions. Figures are as reported and may be revised. Shareholders considering participation in any tender offer or secondary sale should consult their own legal, tax, and financial advisors.
Tax disclaimer: This article is general educational content only and does not constitute tax, legal, or financial advice. Tax treatment of secondary transactions varies significantly based on equity type, holding period, state of residence, individual circumstances, and other factors. Consult a qualified CPA, tax attorney, or financial advisor before making any transaction decision. Earlyasset, Inc. is not a tax advisor and does not provide tax guidance.